Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,678,471
+$649,837 QoQ
Shares Held
2,887
+3.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#181
of 506 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. ARGX ranks #1 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,678,471 | 2,887 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,028,634 | 2,778 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,359,705 | 2,806 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,068,118 | 2,804 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,546,172 | 2,805 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,417,516 | 2,395 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $688,800 | 1,120 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $577,857 | 1,066 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $384,025 | 893 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $360,253 | 915 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $405,918 | 1,067 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $529,977 | 1,078 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $381,545 | 979 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $337,184 | 905 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $375,041 | 990 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $408,478 | 1,157 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $333,793 | 881 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $187,294 | 594 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $164,939 | 471 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $118,384 | 392 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $104,772 | 348 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $85,095 | 309 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $65,582 | 223 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $37,802 | 144 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,252 | 10 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||